跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
D5-LRSAPH - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
D5-LRSAPH
Approved
STANDARD
D5-LRSAPH
Althea Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c69f0fe69d9868b1
Company
Althea Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c69f0fe69d9868b1
Drug Approval Philippines Name
D5-LRSAPH
Product Name
D5-LRSAPH
Registration Number
DRP-12162
Brand Name
D5-LRSAPH
Generic Name
5% Dextrose in Lactated Ringer's Solution
Dosage Form
Infusion (see reverse for formulation)
Dosage Strength
Formulation Each 100 mL contains: Dextrose (as monohydrate) Sodium Chloride Sodium Lactate Potassium Chloride Calcium Chloride 600 mg 310 mg 30 mg 20 mg
Manufacturer
Althea Pharma Pvt. Ltd.
Importer
Sapphire Lifesciences Pvt. Ltd.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
29 June 2022
Expiry Date
29 June 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c69f0fe69d9868b1
Type
Standard
Back to Philippines FDA Approvals